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The intellectual disability protein RAB39B
selectively regulates GluA2 trafﬁcking to
determine synaptic AMPAR composition
Maria Lidia Mignogna1,2,3,*, Maila Giannandrea1,2,*, Antonia Gurgone1,3, Francesca Fanelli4, Francesco Raimondi4,
Lisa Mapelli5, Silvia Bassani5, Huaqiang Fang6, Eelco Van Anken7, Massimo Alessio7, Maria Passafaro5,
Silvia Gatti2, Jose´ A. Esteban8, Richard Huganir6 & Patrizia D’Adamo1
RAB39B is a member of the RAB family of small GTPases that controls intracellular vesicular
trafﬁcking in a compartment-speciﬁc manner. Mutations in the RAB39B gene cause
intellectual disability comorbid with autism spectrum disorder and epilepsy, but the impact of
RAB39B loss of function on synaptic activity is largely unexplained. Here we show that
protein interacting with C-kinase 1 (PICK1) is a downstream effector of GTP-bound RAB39B
and that RAB39B-PICK1 controls trafﬁcking from the endoplasmic reticulum to the Golgi and,
hence, surface expression of GluA2, a subunit of alpha-amino-3-hydroxy-5-methyl-4-iso-
xazole propionic acid receptors (AMPARs). The role of AMPARs in synaptic transmission
varies depending on the combination of subunits (GluA1, GluA2 and GluA3) they incorporate.
RAB39B downregulation in mouse hippocampal neurons skews AMPAR composition towards
non GluA2-containing Ca2þ -permeable forms and thereby alters synaptic activity, speciﬁ-
cally in hippocampal neurons. We posit that the resulting alteration in synaptic function
underlies cognitive dysfunction in RAB39B-related disorders.
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T
he human RAB39B gene, which maps to the distal Xq28
locus, encodes RAB39B, a member of the RAB GTPases,
small monomeric GTPases belonging to the RAS-like
GTPase superfamily, that have a key role in the regulation of
intracellular vesicular trafﬁcking1. Indeed, RAB GTPases are
physically associated with speciﬁc organelles, through speciﬁc
effector protein interaction, and act as a network to regulate both
spatially and temporally the transport of speciﬁc vesicles
switching from the active GTP-bound and the inactive GDP-
bound state2,3. RAB and RAB-associated proteins have been
shown to play an important role in a number of rare monogenic
as well as multifactorial diseases4,5 characterized by cognitive
deﬁcit. In particular, previous work on X-linked intellectual
disability (XLID) has identiﬁed mutations in the GDI1 gene that
cause loss of function of the RAB-interacting protein aGDI6,7.
RAB GTPases and interacting proteins are abundantly expressed
in the central nervous system across species, and Gdi1 mouse
models have been relevant to demonstrate the causal link of aGDI
loss of function with deﬁcits in glutamate release and cognitive
impairment8,9. Our group previously demonstrated that loss-of-
function mutations in human RAB39B gene are associated with
XLID comorbid with autism spectrum disorder and seizures10
and also comorbid with early onset of Parkinson’s disease11.
Moreover, it was reported that also a 0.5-Mb tandem copy-
number gain at distal Xq28 including RAB39B was linked to
XLID12. We deﬁned that RAB39B is a neuronal-speciﬁc protein
localized at the Golgi compartment, but its functional role is
unknown10. The demonstrated link with a human genetic disease
urged us to deﬁne the functional role of RAB39B in neurons and
the potential link to cognitive function.
In the present study, we deﬁne that RAB39B interacts with
protein interacting with C-kinase 1 (PICK1), which became an
attractive target for further studies. Previous studies deﬁned the
functional role of PICK1 in synaptic alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid receptor (AMPAR) surface
expression, trafﬁcking and post-synaptic targeting13–18, but the
mechanism of AMPAR biogenesis, assembly and trafﬁcking is
poorly understood. In hippocampal CA1 pyramidal neurons,
AMPARs are hetero-tetramers formed in the endoplasmic
reticulum (ER)19–21 mostly composed of GluA1/GluA2 or
GluA2/GluA3 hetero-dimers22. Export of AMPARs from the
ER requires the interaction of the C-terminal domain of AMPAR
subunits with other proteins. In fact, synapse-associated
protein 97 (SAP97) interacts with the immature GluA1
C-terminal domain23 early in the secretory pathway24, while
GluA2 C-terminal domain interacts with PICK1, which is
necessary for GluA2 exit from the ER. Thus, PICK1 selectively
binds GluA2/GluA3 heterodimers for exit from the ER to Golgi
compartment25.
Given the RAB39B–PICK1 interaction and the Golgi localiza-
tion of RAB39B, here we hypothesize that RAB39B might be a
key molecule fundamental to regulate a speciﬁc secretory
trafﬁcking step of GluA2 AMPAR subunit. Supporting this idea,
Rab39b-silenced mouse hippocampal neurons show increased
GluA2 immature form suggesting ER retention. This result
provokes, as a ﬁnal step, a reduction in the amount of GluA2
AMPAR subunits at the post-synaptic membrane, leading to the
formation of GluA2-lacking, Ca2þ -permeable AMPARs, often
associated with immature synapses and cognitive impairment26.
We report here that RAB39B is the key molecule regulating the
translocation of GluA2/GluA3 heterotetramers into the Golgi.
Indeed, in the absence of RAB39B, AMPARs arrangement at the
post-synaptic site is misregulated, which provides an explanation
for the involvement of RAB39B mutations in the aetiology of ID
and autism spectrum disorder.
Results
GTP-bound RAB39B interacts with PICK1. To understand the
causal link between XLID and gene defects associated with
RAB39B, we set out to map the role of RAB39B in vesicular
trafﬁcking. As a ﬁrst step, we searched for downstream
effectors of RAB39B by use of a yeast two-hybrid screening
(Supplementary Fig. 1a–c). With the human full-length RAB39B
protein as bait, by screening a human fetal brain cDNA library we
identiﬁed a protein originally described as protein interacting
with C-kinase 1 (PICK1) as the strongest interacting molecule. In
agreement with our results from the two-hybrid screen, recom-
binant GST-RAB39B locked in the active state with the non-
hydrolysable GTP analogue GTPgS and the dominant active
GST-RAB39B Q68L efﬁciently pulled down PICK1, as compared
with GDP-bound or dominant-negative GST-RAB39B S22N,
using whole-brain lysate of murine origin (Fig. 1a,b). Instead,
recombinant GST-RAB39A, sharing 76% identity at protein level
with RAB39B, did not pull down PICK1 (Supplementary Fig. 1d).
GST-RAB39B GTPgS likewise pulled down PICK1, obtained
by in vitro transcription and translation, which indicated that
PICK1 interacts directly with RAB39B, and mostly in its GTP-
bound state (Fig. 1c). Furthermore, myc-tagged PICK1 co-
immunoprecipitates with ﬂag-tagged RAB39B from lysates of
HEK293T cells in which the two constructs were co-expressed
(Fig. 1d). Finally, we performed the reverse pull down using GST-
PICK1 and found that it pulled down RAB39B from the mouse
brain lysate, as well as previously identiﬁed interacting proteins
PKCa27,28 and the GluA2 AMPAR subunit29 (Fig. 1e).
RAB39B effector-binding region interacts with PICK1 PDZ
domain. To deﬁne how the two proteins interact at the molecular
level, COS7 cells were transfected with RAB39B or PICK1 mutant
constructs and interactions were tested again by pull down assays.
Since GST-PICK1 did not pull down RAB39B construct lacking a
stretch (ﬂag-DER, aa 35–49) corresponding to the canonical
effector-binding region as present in all RAB proteins30, we
concluded that the association between RAB39B and PICK1 is a
conventional RAB-effector protein interaction (Fig. 2a). To better
deﬁne the residues involved in the PICK1-RAB39B effector-
binding region, RAB39B constructs carrying different point
mutations were used (ﬂag-D38A, ﬂag-V41G42V43AAA or ﬂag-
D44F45AA). Such RAB39B constructs were generated based on
the predicted structural complex between RAB39B and PICK1
PDZ (see below). Consistently with structure predictions, GST-
PICK1 did not pull down RAB39B construct carrying D44 and
F45 mutated to alanines (aa D44F45AA), indicating that such
amino-acid pair in the N-terminal half of the b2-strand of
RAB39B play a central role in the association between RAB39B
and PICK1 (Fig. 2a). PICK1 is a PDZ- and BAR-domain-contain-
ing protein. GST-RAB39B GTPgS pulled down recombinant
myc-tagged PDZ domain (myc-PDZ; aa 23–99), but not ﬂag-
tagged recombinant PICK1 lacking the PDZ domain (ﬂag- D 121,
aa 1–121; Fig. 2b). Thus, the interface between the two interacting
proteins involves amino acids D44 and F45 of the ER domain of
RAB39B and, respectively, the PDZ domain of PICK1.
The PDZ domain of PICK1 has been shown before to interact
with a variety of proteins31,32, and point mutations within the
PDZ domain of lysine 83 (K83) or of both lysine 27 (K27) and
aspartate 28 (D28) with alanines abolished protein
binding29,31,33,34. Since GST-RAB39B GTPgS pulled down full-
length myc-PICK with the K83A substitution (myc-K83A), but
not with the K27D28AA substitutions (myc-KDAA), we
concluded that K27 and D28 in the PDZ domain is key for the
interaction of PICK1 with RAB39B (Fig. 2b).
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In agreement with our in vitro binding assays, we co-expressed
ﬂag-RAB39B and myc-PICK1 constructs in COS7 cells that lack
the corresponding endogenous proteins (Fig. 3). Pearson’s
correlation coefﬁcient (PCC) analysis on immunoﬂuorescence
indicated that RAB39B and PICK1 co-localized at the perinuclear
region and at the plasma membrane (ﬂag-RAB39B/myc-PICK1:
n¼ 14 cells, PCC¼ 0.70; Fig. 3b,h). As a control of speciﬁcity of
RAB39B co-localization with PICK1, we co-expressed GFP-
RAB39A with myc-PICK1, because RAB39A is endogenously
expressed in COS7 cells. PCC analysis revealed that PICK1 highly
co-localized with RAB39B but not with RAB39A (GFP-RAB39A/
myc-PICK1: n¼ 27 cells, PCC¼ 0.29, adjusted P-value for
multiple comparison (P-adj.)¼ 1E 08; Supplementary
Fig. 2a–c). Moreover, PCC from immunoﬂuorescence on co-
transfection of the relevant mutant constructs in COS7 cells
showed that the co-localization of PICK1 and RAB39B was
signiﬁcantly abolished when either RAB39B is mutated in the
D44F45AA (ﬂag-RAB39B D44F45AA/myc-PICK1: n¼ 14 cells,
PCC¼ 0.23, P-adj.¼ 1.7E 08; Fig. 3g,h) or PICK1 is mutated in
the PDZ domain (ﬂag-RAB39B/myc-PICK1 KDAA: n¼ 23 cells,
PCC¼ 0.22, P-adj.¼ 1.7E 08; Fig. 3c,h).
RAB39B–PICK1 interaction is necessary and sufﬁcient for
GluA2 trafﬁcking. Given that RAB proteins direct vesicular
transport2 and previous studies deﬁned the functional role
of PICK1 in GluA2 but not GluA1 AMPAR subunit
trafﬁcking14,25,35, we hypothesized that based on RAB39B and
PICK1 interaction, they jointly coordinate trafﬁcking of GluA2,
but not of GluA1. To test these assumptions, we transfected into
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Figure 1 | RAB39B interacts with PICK1. (a–c, upper panel) Representative western blots (n¼ 3 experimental replicates) of GST-RAB39B GDP/GTPgS and
GST-RAB39B S22N/Q68L pull down. (a,b) Input: mouse brain lysate. (c) Input T&T: PICK1 in vitro transcribed and translated. (a–c, lower panel) Histograms
show the percentage±s.e.m. of PICK1 binding to GST-RAB39B GDP versus GST-RAB39B GTPgS. (d) Representative western blot (n¼ 3 experimental
replicates) of co-immunoprecipitation of myc-PICK1 and ﬂag-RAB39B. Input: HEK293T cells; NT: non-transfected cells. (e) Representative western blots
(n¼ 3 experimental replicates) of GST-PICK1 pull down. Input: mouse brain lysate.
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the heterologous COS7 cell system tagged constructs of RAB39B,
PICK1, GluA1 and GluA2 either individually or in combination.
Pearson’s correlation coefﬁcient was measured to verify co-
localization between these proteins (Fig. 4) and the receptor
trafﬁcking to the plasma membrane by total internal reﬂection
ﬂuorescence (TIRF) (Fig. 5).
When expressed alone, GFP-GluA1 as well as GFP-GluA2
localized at the perinuclear region (Fig. 4a). Co-expression of ﬂag-
RAB39B did not change the localization of either GFP-GluA1 or
GFP-GluA2, neither RAB39B co-localized with GluA1 and
GluA2 (ﬂag-RAB39B/GFP-GluA1: n¼ 26 cells, PCC¼ 0.09,
ﬂag-RAB39B/GFP-GluA2: n¼ 26 cells, PCC¼ 0.06; Fig. 4c,d,i).
Co-expression of myc-PICK1 and GFP-GluA1 did not show
co-localization (myc-PICK1/GFP-GluA1: n¼ 29 cells, PCC¼
 0.01; Fig. 4e,i). Conversely, GFP-GluA2 co-clustered with
myc-PICK at the perinuclear region when co-expressed, as has
been previously reported29 (myc-PICK1/GFP-GluA2: n¼ 38
cells, PCC¼ 0.66; Fig. 4f,i).
Remarkably, GFP-GluA2 co-localized with ﬂag-RAB39B only
when co-expressed with myc-PICK1, and a signiﬁcant correlation
was found between RAB39B and GluA2 depending on the
presence of PICK1 in the cells (ﬂag-RAB39B/GFP-GluA2 with
PICK1: n¼ 12 cells, PCC¼ 0.71, P-adj.¼ 1.8E 08 comparing
ﬂag-RAB39B/GFP-GluA2 in PICK1 absence versus presence;
Fig. 4h,i). In contrast, GFP-GluA1 never showed co-localization
regardless of the co-expression of RAB39B and PICK1
constructs (ﬂag-RAB39B/GFP-GluA1 with PICK1: n¼ 24 cells,
PCC¼ 0.06; Fig. 4g,i).
Next, we then demonstrated receptor trafﬁcking to the plasma
membrane by TIRF. Co-expression of ﬂag-RAB39B did not drive
the plasma membrane translocation of either GFP-GluA1 or
GFP-GluA2 (Fig. 5a,b). Remarkably, in triple transfected cells,
ﬂag-RAB39B mediated the GFP-GluA2 translocation to the
plasma membrane in the presence of myc-PICK1 (Fig. 5d) but
not GFP-GluA1 (Fig. 5c).
All together our results clearly indicate that the effector-
binding region of RAB39B interacts with the PDZ domain of
PICK1, also required for interaction with the GluA2 AMPAR
subunit36. We also demonstrated that the RAB39B PICK1
interaction is necessary for the RAB39B-driven trafﬁcking of
GluA2 cargo. PICK1-mediated functional linkage between
RAB39B and GluA2-containing AMPAR relies on PICK1 dimer
to act as a scaffold that hosts the other two proteins. In fact,
GluA2 co-immunoprecipitates with PICK1 and RAB39B in a wild
-type mouse brain lysate, but not in the Pick1-knockout brain,
demonstrating the existence of the endogenous complex and that
PICK1 acts as the bridge between RAB39B and GluA2 (Fig. 5e).
A model of interactions among the RAB39B-PICK1-GluA2. To
gain insight, at the atomic level, into the supramolecular orga-
nization of RAB39B, PICK1 and GluA2 AMPAR subunit, we
modelled the structure of RAB39B:2PICK1:GluA2 complex
(Fig. 6a and Supplementary Methods). This required comparative
modelling and rigid-body docking to predict structure and
interaction modes of PICK1 and RAB39B (see Methods). In
contrast, the complex between the GluA2 C-terminus (GluA2Ct;
aa 858-ESVKI-862) and PICK1 was extracted from a conforma-
tional ensemble solved by NMR37. In our structural model, the
N-terminal half of the b2-strand of RAB39B (that is, amino-acid
stretch 43–47 of the effector-binding region) interacts with the
PDZ domain of PICK1 in a similar and partially overlapping
manner as GluA2Ct, which is a b-strand as well (Fig. 6a–c). The
major portions of RAB39B participating in the interface with
PICK1 PDZ include (a) the 43–47 segment of the b2-strand,
which makes inter-backbone and inter-side chain interactions
with PICK1 bB and with aB; (b) switch 1 (swI) that interacts with
the PICK1 bA/bB loop and aB; and (c) the switch 2 (swII) that
interacts with PICK1 bC as well as the bA/bB and bB/aA loops (b
and c). The predicted complex highlights D44 and F45 in the
N-terminal half of the b2-strand as playing a central role in the
interface, D44 making a salt bridge with K83 of PICK1 PDZ. Such
a centrality of D44 and F45 has been validated by in vitro
experiments (Fig. 3). Remarkably, the PICK1 bA/bB loop
of PDZ holds the K27-D28 pair that we found essential for
PICK1RAB39B interaction. Structure predictions indicate D28
as more important than K27 in RAB39B recognition. Indeed, K27
is buried at the bB/aB interface, its positively charged nitrogen
atom being about 9Å from the carboxylate oxygen atoms of D38
on the swI of RAB39B, and we postulate that the effect of the
K27A mutation on RAB39B recognition, if any, is indirect. In
contrast, D28 recognizes the G protein via a salt bridge with R70
in swII. Structure prediction therefore suggests that the
interactions of RAB39B and GluA2 with the PDZ domain of
PICK1 are mutually exclusive. In line with evidence that PICK1
can dimerize33, the structural model suggests that dimerization of
PICK1 is a prerequisite for simultaneous recognition of both
RAB39B and GluA2 each by one of the PICK1 molecules in the
PICK1 dimer (Fig. 6a–c). The existence of such complex is
supported by our co-immunoprecipitation experiments shown
above.
RAB39B directs GluA2 trafﬁcking in neurons. The two most
prevalent AMPAR variants contain a tandem of either GluA1 and
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GluA2 or GluA2 and GluA3 subunits19–21. Exports of GluA1/
GluA2 hetero-tetramers from the ER requires GluA1 interaction
with SAP97 (refs 23,24), while GluA2/GluA3 hetero-tetramers
need GluA2 interaction with PICK1 (ref. 25).
To assess whether the RAB39B-PICK1 tandem directs
trafﬁcking of GluA2/GluA3 hetero-tetramers in their endogenous
neuronal context, we ﬁrst analysed the intracellular localization of
RAB39B and PICK1 in ﬂag-RAB39B-transfected primary mouse
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shows the Pearson’s correlation coefﬁcients (PCC; means±s.e.m.) for each transfection. PCC was calculated between proteins highlighted with a bold ‘þ ’.
Signiﬁcant statistical differences were found comparing: ﬂag-RAB39B/GFP-GluA1 PCC (n¼ 26 cells; three experimental replicates; PCC¼0.09, P
adj.¼ 1.8E08) and ﬂag-RAB39B/GFP-GluA2 PCC (n¼ 22 cells; three experimental replicates; PCC¼0.06, P adj.¼ 1.8E08) to ﬂag-RAB39B/myc-
PICK1 PCC (n¼ 14 cells; three experimental replicates; PCC¼0.70); myc-PICK1/GFP-GluA1 PCC (n¼ 29 cells; three experimental replicates;
PCC¼ 0.01, P adj.¼ 1.8E08) to myc-PICK1/GFP-GluA2 PCC (n¼ 38 cells; three experimental replicates; PCC¼0.66); ﬂag-RAB39B/GFP-GluA2 PCC
in the absence or presence of PICK1 (PCC in the presence of PICK1¼0.71; n¼ 12 cells; three experimental replicates; P adj.¼ 1.8E08). Benjamini–
Hochberg procedure used to test statistical signiﬁcance. ***Po0.001.
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hippocampal neurons (Supplementary Fig. 3). Flag-RAB39B
appears to partially co-localize with PICK1 in the cell body,
instead of along dendrites (Supplementary Fig. 3a). In a similar
manner, ﬂag-RAB39B and PICK1 co-localize in part with
the ER or Golgi markers, calreticulin and GM130, respectively
(Supplementary Fig. 3b,c). No co-localization was observed
between ﬂag-RAB39B and adaptor protein 2 (AP2), which was
used as a negative control10. Although RAB39B and PICK1 are
certainly involved in many other intracellular pathways, our data
support that RAB39B–PICK1 interaction has a role in cargo
trafﬁcking between the ER and the Golgi compartments.
We then analyse the effect of Rab39b downregulation
in transduced murine primary hippocampal neurons with
previously described shRab39b and shScramble lentiviral parti-
cles10. Silencing with shRab39b led to a 40% downregulation of
RAB39B expression levels (mean±s.e.m., shScramble: 1.1±0.13,
shRab39b: 0.68±0.08; n¼ 3; t-test P¼ 0.035), without affecting
protein expression levels of PICK1, GluA1, GluA2 and GluA3
(Supplementary Fig. 4).
We ﬁrst determined the effect of RAB39B silencing on the
intracellular localization of PICK1 GluA1, GluA2 and GluA3 in
the murine hippocampal neurons by immunoﬂuorescence at 14
DIV. We found an increase in PICK1, GluA2 and GluA3 levels in
the cell body of shRab39b-treated neurons as compared with the
neurons treated with the control shRNA (mean±s.e.m., PICK1
shScramble n¼ 21: 2.98±0.28, shRab39b n¼ 21: 4.25±0.35;
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Figure 5 | Validation of RAB39B–PICK1–GluA2 complex. Representative TIRF and epiﬂuorescence images of COS7 cells transfected with ﬂag-RAB39B
(red) and GFP-GluA1 (green) or GFP-GluA2 (green), in the absence (a–b) or presence (c,d) of PICK1 (blue). Scale bar, 10mm. (e) Representative western
blots (n¼ 3 experimental replicates) of immunoprecipitation from WT and Pick1 KO mouse brain lysates (Input). The 31-kDa contaminant bands reacting
with the anti-RAB39B correspond to the protein G as shown in the mock elution of protein G Sepharose-4 fast ﬂow beads (in conditions of elution adopted
as described in Methods69).
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t-test P¼ 0.009; GluA2 shScramble n¼ 9: 0.60±0.05,
shRab39b n¼ 5: 0.88±0.05; t-test P¼ 0.003; GluA3 shScramble
n¼ 6: 0.42±0.03, shRab39b n¼ 7: 0.62±0.04; t-test P¼ 0.005;
Fig. 7a and Supplementary Fig. 5a), which suggests that there
is a defect in protein trafﬁcking when levels of RAB39B are
downregulated.
Next, we analysed the effect of RAB39B silencing on the
intracellular trafﬁcking in murine hippocampal neurons of the
AMPAR subunits GluA1, GluA2 and GuA3 by examining their
glycosylation status. Both AMPAR subunits are N-glycosylated
and their N-glycans are subsequently modiﬁed in the ER before
they are targeted to the plasma membrane. We therefore
deglycosylated lysates from RAB39B silenced or control neurons
with either Endo-b-N-acetylglucosaminidase H (EndoH),
which removes only unmodiﬁed N-glycans25, or, as a control,
with peptide-N-Glycosidase F (PNGasef), which removes all
N-glycans, before analysis of the AMPAR subunits by immuno-
blotting. In the control lysates two isoforms, differing in their
mobility in gel, were detected for GluA1, GluA2 and GluA3 on
treatment with EndoH: an upper band, corresponding to the
mature isoform (as it acquired partial EndoH resistance), and a
lower band, corresponding to the immature isoform (as it
acquired no EndoH resistance). The ratio between the two bands
thus is a measure for AMPAR subunit maturation. As such, we
determined that GluA2 and GluA3 maturation was impaired in
shRab39b-treated neurons compared with the control neurons
(mean±s.e.m., GluA2 shScramble: 0.96±0.05, shRab39b:
0.52±0.05; n¼ 3; t-test P¼ 0.002; GluA3 shScramble:
1.0±0.07, shRab39b: 0.0±0.0; n¼ 3; t-test P¼ 0.0001; Fig. 7b),
while GluA1 maturation was not affected by the shRab39b
silencing (mean±s.e.m., shScramble: 1.29±0.21, shRab39b:
1.28±0.15; n¼ 3; t-test P¼ 0.9; Fig. 7b).
We next examined the role of the RAB39B-PICK1 tandem in
post-Golgi trafﬁcking of AMPAR subunits along dendrites. We
noted that, in RAB39B-silenced cells, the increased PICK1 as well
as GluA2 and GluA3 density at the cell body (Fig. 7a and
Supplementary Fig. 5a) was mirrored by a decreased PICK1,
GluA2 and GluA3 density along dendrites (mean±s.e.m., PICK1
shScramble n¼ 14: 17.82±1.13, shRab39b n¼ 15: 14.98±0.61;
t-test P¼ 0.03; GluA2 shScramble n¼ 10: 0.82±0.02, shRab39b
n¼ 5: 0.49±0.02; t-test P¼ 2.8E 7; GluA3 shScramble n¼ 7:
1.24±0.06, shRab39b n¼ 10: 0.62±0.07; t-test P¼ 1.6E 5;
Fig. 7c and Supplementary Fig. 5b). Likewise, downregulation of
RAB39B resulted in a decrease in surface density of GluA2 as
measured by immunostaining without permeabilization of the
cells (mean±s.e.m., GluA2 shScramble n¼ 89: 0.88±0.02,
shRab39b n¼ 70: 0.72±0.03; t-test P¼ 0.006). Curiously, surface
expression of GluA1 slightly increased on RAB39B silencing
(mean±s.e.m., shScramble n¼ 41: 0.62±0.02, shRab39b n¼ 40:
0.77±0.02; t-test P¼ 0.03; Fig. 7d), mirrored by a signiﬁcant
increase along dendrites (mean±s.e.m., GluA1 shScramble
n¼ 10: 0.87±0.02, shRab39b n¼ 10: 1.05±0.04; t-test
P¼ 0.0007; Fig. 7c and Supplementary Fig. 5b). The reintroduc-
tion of RAB39B by co-transducing shRab39b-treated neurons
with a cherryRab39b-rescue lentiviral particles recovered the
intracellular distribution of PICK1 (shRab39b versus Rab39b-
rescue n¼ 8; t-test P¼ 0.002), GluA2 (shRab39b versus Rab39b-
rescue n¼ 11; t-test P¼ 0.004) and GluA3 (shRab39b versus
Rab39b-rescue n¼ 12; t-test P¼ 0.007) and GluA1 (shRab39b
versus Rab39b-rescue n¼ 10; t-test P¼ 0.006) and GluA2
(shRab39b versus Rab39b-rescue n¼ 8; t-test P¼ 0.01) surface
expression (Fig. 7a,c,d and Supplementary Fig. 5a,b).
Finally, downregulation of RAB39B has a mild effect on spine
morphology without altering spine number and type (mean±-
s.e.m., spine length shScramble n¼ 26: 1.20±0.02, shRab39b
n¼ 30: 1.12±0.02; t-test P¼ 0.05; spine width shScramble
n¼ 25: 0.68±0.01, shRab39b n¼ 29: 0.64±0.009; t-test
P¼ 0.02; Supplementary Fig. 5c).
These results indicate that in neurons the RAB39B-PICK1
tandem directs trafﬁcking speciﬁcally of GluA2/GluA3 hetero-
tetramers to the Golgi and, consequently, regulates GluA2 cell
surface expression and spine morphology.
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RAB39B determines AMPAR composition and synaptic
transmission. Since our results so far demonstrated that RAB39B
is key to ensure efﬁcient trafﬁcking of GluA2/GluA3 to the Golgi
compartment, and, hence, its cell surface expression, we reasoned
that ultimately RAB39B controls the availability of GluA2 and
thus AMPAR composition at the post-synapses. Because the
subunit composition, in turn, determines Ca2þ permeability of
the AMPARs and therefore impacts on synaptic transmission, we
asked whether RAB39B-PICK-directed trafﬁcking of GluA2/
GluA3 is key for glutamatergic synapses. To this end, we per-
formed electrophysiological recordings on primary murine hip-
pocampal neurons that were infected with the shRab39b or
control shScramble lentiviruses at low doses to ensure that most
pre-synaptic inputs would come from non-infected (unaltered)
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neurons, while post-synaptic outputs would come from infected
(silenced) neurons (Supplementary Fig. 6a,b). The amplitude of
miniature EPSCs was slightly but signiﬁcantly larger in RAB39B-
silenced neurons (mean±s.e.m. in pA, shScramble n¼ 14:
 17.1±1.1, shRab39b n¼ 13:  22.9±1.9; t-test Po0.01)
(Fig. 8a–c). The miniature frequency, however, was unaffected,
suggesting that indeed RAB39B silencing occurred mostly in
post-synaptic neurons due to the low-density lentiviral infection
(Fig. 8c). Interestingly, kinetic analysis of the miniature currents
indicated that RAB39B silencing accelerated decay (mean±s.e.m.
in ms, shScramble n¼ 14: 2.60±0.32, shRab39b n¼ 13:
1.71±0.05; t-test Po0.01) but not rise times of synaptic currents
(Fig. 8b,c). The speciﬁcity of shRab39b effect was determined
using a rescue experiment. Electrophysiological recordings were
carried out on primary murine hippocampal neurons that were
infected with the shRab39b or control shScramble lentiviruses at
multiplicity of infection (MOI) 1 to ensure that pre-synaptic
inputs and post-synaptic outputs come from infected (silenced)
neurons and after 6 days in culture transfected with a ﬂag-
RAB39B-rescue, as previously described10 (Supplementary
Fig. 6c,d). The reintroduction of RAB39B recovered the
amplitude and kinetic of the miniature currents (Fig. 8d–g).
Since RAB39B directs GluA2 trafﬁc and thus cell surface
expression, we attributed the electrophysiological changes on
RAB39B silencing to an altered subunit composition of synaptic
AMPARs. To test this hypothesis, we monitored inward
rectiﬁcation of AMPAR-mediated synaptic responses in organo-
typic hippocampal slices from mice that were injected in the CA1
with the relevant lentiviruses (shScramble or shRab39b) by
evoked EPSCs, recorded at  60mV and þ 40mV. The ratio of
synaptic responses at þ 40mV over responses at  60mV was
calculated to serve as a rectiﬁcation index (R.I.). We found a
signiﬁcant increase in the R.I. of RAB39B silenced neurons
(mean±s.e.m., uninfected n¼ 6: 1.801±0.175; shScramble
n¼ 6: 1.403±0.166; shRab39b n¼ 6: 2.998±0.297; ANOVA:
Po0.0001) (Fig. 8h,i), indicative of enrichment at synapses of
inward rectifying AMPARs. Since GluA2-lacking AMPARs in
fact are inward rectifying38 we concluded that the alterations in
synaptic transmission are due to a lowered GluA2 availability.
This interpretation also ﬁts with our observation that RAB39B
down regulation leads to increased miniature EPSC amplitude
(Fig. 8a–g), in agreement with the higher conductance of GluA2-
lacking AMPARs39. Finally, we tested whether long-term
depression (LTD) was altered in RAB39B down regulated cells,
given the involvement of PICK1 in activity-dependent AMPAR
endocytosis and LTD15,40. To this end, we assessed NMDAR-
dependent LTD in shRab39b-, shScramble- and non-infected
CA1 neurons (Fig. 8j). After LTD induction (500 stimuli at 1Hz,
with postsynaptic depolarization at  40mV), AMPAR-mediated
synaptic responses were equally depressed in the three conditions.
These results suggest that, in contrast with PICK1, RAB39B is not
required for LTD. Therefore, RAB39B does not appear to be
involved in activity-dependent AMPAR endocytosis or recycling.
Discussion
Our results deﬁne RAB39B in tandem with its downstream
effector PICK1 as a key molecule dedicated to GluA2 AMPAR
subunit trafﬁcking. We demonstrate a molecular complex where
the dimerization of PICK1 is a prerequisite for simultaneous
recognition of both RAB39B and GluA2 by each one of the PDZ
domains of PICK1, in a PICK1 dimer conformation.
Subsequently, the remarkable inference from this study is that
RAB39B interacting with PICK1 ensures selectively the GluA2/
GluA3 AMPAR exit from the ER and its maturation entering into
the cis-Golgi (Fig. 9). Indeed, despite the demonstrated relevance
of regulators of AMPAR surface expression, trafﬁcking and post-
synaptic targeting and human memory formation and main-
tenance (for example, KIBRA41 and TMS4SF2 (ref. 42)), only few
proteins that are involved in the trafﬁcking between the ER and
the Golgi of AMPAR subunits are known. Exit of plasma
membrane proteins from the ER poses a rate-limiting step and is
subjected to tight control, to safeguard that only properly folded
and assembled complexes leave the ER and are transported to the
cis-Golgi43,44, to ﬁnally reach the plasma membrane. However,
rules governing subunit assembly and the progression of distinct
AMPAR complexes through the secretory pathway are largely
unknown. It is known that AMPAR subunits preferentially
homodimerize soon after the translocation in the ER and
tetramerize before ER exit in GluA1/GluA2 and GluA2/GluA3
complexes25. Greger and coauthors25 found unexpected
differences in the subcellular localization and ER export kinetics
of the GluA1 and GluA2 subunits. Whereas GluA1 receptor exit
the ER and trafﬁc to the surface, GluA2 partly remains in the ER,
suggesting the existence of an intracellular GluA2 reserve pool.
GluA2 ER pool is, at least partly, associated with GluA3, whereas
Figure 7 | PICK1, AMPARs neuronal localization, maturation and GluA2 surface expression. (a) Quantiﬁcation of PICK1 (shScramble n¼ 21 cells;
shRab39b n¼ 21 cells; Rab39b-rescue n¼ 8 cells; Student’s t-test shScramble versus shRab39b P¼0.009; Rab39b-rescue versus shRab39b P¼0.002),
GluA1 (shScramble n¼ 10 cells; shRab39b n¼ 10 cells; Rab39b-rescue n¼9 cells), GluA2 (shScramble n¼ 9 cells; shRab39b n¼ 5 cells; Rab39b-rescue
n¼ 11 cells; Student’s t-test shScramble versus shRab39b P¼0.003; Rab39b-rescue versus shRab39b P¼0.004) and GluA3 (shScramble n¼ 6 cells;
shRab39b n¼ 7 cells; Rab39b-rescue n¼9 cells; Student’s t-test shScramble versus shRab39b P¼0.03; Rab39b-rescue versus shRab39b P¼0.04) cell
body density in shScramble-, shRab39b- and Rab39b-rescue-treated mouse hippocampal neurons. (b) Quantiﬁcation of the ratio between mature (1) and
immature (2) forms of AMPARs in shRab39b- compared with shScramble-treated neurons after PNGasef or EndoHf digestion. NT: non-treated neurons.
Representative western blots (lower panels) showing the maturation ratio for GluA1 (n¼ 3 experimental replicates), GluA2 (n¼ 3 experimental replicates;
Student’s t-test P¼0.002) and GluA3 (n¼ 3 experimental replicates; Student’s t-test P¼ 1.28E04). (c) Quantiﬁcation of PICK1 (shScramble n¼ 14 cells;
shRab39b n¼ 15 cells; Rab39b-rescue n¼8 cells; Student’s t-test shScramble versus shRab39b P¼0.03; Rab39b-rescue versus shRab39b P¼0.01), GluA1
(shScramble n¼ 10 cells; shRab39b n¼ 10 cells; Rab39b-rescue n¼9 cells; Student’s t-test shScramble versus shRab39b P¼ 7.4E04; Rab39b-rescue
versus shRab39b P¼ 8.1E04), GluA2 (shScramble n¼ 10 cells; shRab39b n¼ 5 cells; Rab39b-rescue n¼9 cells; Student’s t-test shScramble versus
shRab39b P¼ 2.8E07; Rab39b-rescue versus shRab39b P¼ 3.1E05) and GluA3 (shScramble n¼6 cells; shRab39b n¼ 7 cells; Rab39b-rescue n¼9
cells; Student’s t-test shScramble versus shRab39b P¼ 1.5E05; Rab39b-rescue versus shRab39b P¼4.7E05) dendrite density in shScramble-,
shRab39b- and Rab39b-rescue-treated mouse hippocampal neurons. (d) Representative images of shRab39b, shScramble and Rab39b-rescue neurons
immunostained without permeabilization for the extracellular N-terminal region of GluA1 and GluA2. Quantiﬁcation of positive puncta at cell surface shows
a signiﬁcant increase of GluA1 (shScramble n¼41 cells; shRab39b n¼40 cells; Rab39b-rescue n¼ 10; Student’s t-test shScramble versus shRab39b
P¼0.03; Rab39b-rescue versus shRab39b P¼0.006) and signiﬁcant decrease of GluA2 (shScramble n¼89 cells; shRab39b n¼ 70 cells; Rab39b-rescue
n¼ 8; Student’s t-test shScramble versus shRab39b P¼0.006; Rab39b-rescue versus shRab39b P¼0.01) subunits. The number of cells belongs
from a minimum of three experimental replicates. *Po0.05; **Po0.01; ***Po0.001.
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GluA1/A2 heteromers are mostly conﬁned to post-ER
compartments. Finally, to become competent for ER export,
AMPARs need to co-assemble with auxiliary proteins. In the
brain, auxiliary subunits of the stargazing/TARP (transmembrane
AMPAR regulatory protein) family and the cornichon family are
physically associated with the channel and regulate their
trafﬁcking and gating45–49. Recently, Cornichon-2/-3 was
described as cargo receptors to selectively bind GluA1, and not
GluA2, in hippocampal neurons, allowing the forward trafﬁcking
of GluA1-containing AMPARs from the ER to Golgi and ﬁnally
their synaptic expression50. Instead, our study identiﬁes RAB39B
as the ﬁrst RAB GTPase regulating a vesicular trafﬁcking step for
the transport of GluA2/GluA3 heteromers into the secretory
pathway.
Finally, our analysis of the steady-state levels of AMPAR
subunits at the post-synaptic membrane of Rab39b silencing
hippocampal neurons demonstrates that the alteration in the
RAB39B-mediated secretory pathway leads to a decrease in
surface GluA2 density and an increase in GluA1 AMPAR
subunits. This observation was conﬁrmed functionally by the
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(red) is normalized to the peak of the shScramble (black), revealing the lower decay kinetic of shRab39b currents (c). (c) Histograms show the average
changes in the mEPSCs peak amplitude, frequency and decay kinetics (shScramble n¼ 14 cells and shRab39b n¼ 13 from three experimental replicates;
Student’s t-test Po0.01). (d) Averages of 100 mEPSCs from shScramble (black) and shRab39b (red) superimposed as in (a) and (e) as in (b). The grey
trace in (f) is the average of 100 mEPSCs from Rab39b-rescue neurons, in which the average peak amplitude and kinetics resembles that of the shScramble
values (peak amplitude  19.2±0.8 pA; tau 2.11±0.21ms, n¼ 10 cells). These results are summarized in the histograms in (g). The number of cells
belongs from a minimum of three experimental replicates. (e) Rectiﬁcation index histogram from uninfected, shScrambled and shRab39b-treated
organotypic slices (n¼ 6 experimental replicates for each condition) and (f) cumulative probability indicate a highly signiﬁcant increase of the rectiﬁcation
index in Rab39b silenced neurons (Student’s t-test Po0,0001 shRab39b versus shScramble; P¼0,0007 shRab39b versus uninfected; P¼0,19 uninfected
versus shScramble). (g) LTD representation of uninfected, shScrambled and shRab39b-treated organotypic slices. **Po0.01; ***Po0.001.
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analysis of the rectiﬁcation properties of AMPAR-mediated
synaptic transmission resulting in an increased rectiﬁcation index
suggestive of an increased fraction of GluA2-lacking AMPARs at
synapses related to the increased amplitude of miniature EPSCs.
Because it was previously described that, in the hippocampus,
heterotetramers of GluA1/GluA2 and GluA2/GluA3 subunits,
together with a smaller contribution from GluA1 homomers,
represent the most common combinations in excitatory
synapses22, we could speculate that altering RAB39B-mediated
early trafﬁcking step of GluA2/GluA3, the result will be an
increase in GluA1 Ca2þ -permeable homomers.
In fact, the AMPA-type glutamate receptors play a critical role
in synaptic plasticity underlying learning and memory by
mediating the majority of fast excitatory synaptic transmission
and by trafﬁcking into and out of the synapse51. The presence of
GluA2 in heteromeric AMPAR renders the channel impermeable
to Ca2þ and Zn2þ , thus inﬂuencing channel kinetic, channel
conductance and synaptic transmission. In contrast, GluA2-
lacking AMPAR is Ca2þ -permeable and is mostly observed in
young animals or after an epoch of plasticity-inducing neuronal
activity52–54. In fact, our results describe a slight alteration in
spine morphology, depicting a scenario of immature spines in
shRab39b-treated neurons, as they are shorter and wider than
control neurons. Previous studies described that Ca2þ -permeable
AMPARs are important in experience-dependent and synaptic
plasticity55. These studies suggest that Ca2þ -permeable
AMPAR play a prominent role in maintaining circuits in a
labile state where further plasticity can occur, thus promoting
metaplasticity56. Moreover, it was shown that the abnormal
expression of Ca2þ -permeable AMPARs is implicated in drug
addiction and memory disorders, with signiﬁcant implication in
the development of therapeutic approaches to these disorders56.
In addition, alteration of the relative proportion of AMPAR
subunits after pathological insults54,57 or in response to
physiological stimuli58 will shift the balance towards homomers
and in turn alter the signalling landscape of the neuron.
Altogether our ﬁndings shed light on the molecular mechan-
isms responsible for the maturation and the trafﬁcking of GluA2/
GluA3 AMPAR in the secretory pathway, and pave the way to
explain the functional role of RAB39B in cognitive disorder.
Unsolved questions remain still open. At ﬁrst, what other
molecules convey the transport competence to RAB39B? One
possibility could be the involvement of additional downstream
effectors proteins that give the directionality and the timing for
RAB39B–PICK1–GluA2 complex movement. GM130 a cis-Golgi
protein involved in accepting vesicles from the ER59,60, as well as
dynein/dynactin motor complex, driving microtubule-dependent
trafﬁcking from the ER to Golgi61 and along dendrites to the
post-synaptic sites62 or myosin Va63 involved in dendritic and
post-synaptic actin-dependent trafﬁcking64 could be the most
reliable factors. At present, RAB39B is required for the transport
of GluA2-containing AMPAR from the ER to the Golgi, but we
cannot assess its involvement from the Golgi to the neuronal
surface. Future studies will undoubtedly be necessary to answer
these questions as well as the availability of Rab39b-null mouse
model to better deﬁne the link between RAB39B-mediated
intracellular trafﬁcking and cognitive disorders.
Methods
Most of the experiments were on mouse hippocampal neurons prepared from
mouse embryos at E18 days. Astroglial feeder layer cultures were prepared from
mouse cortices at post-natal day 2. Mice were C57Bl/6N genetic background and
were obtained from Charles River, Italy. Mice were euthanized in accordance with
‘Institutional Animal Care and Use Committee San Raffaele (IACUC)’ at San
Raffaele Scientiﬁc Institute, Milan, Italy and approved by the Italian National
Ministry of Health, IACUC ID 470 and in accordance with the guidelines
established by the European Community Council Directive of 24 November 1986
on the use of animals in research (86/609/EEC).
Plasmids generation. pGEX-RAB5 and pGEM-p110b were a gift from Professor
M. Zerial (Max Planck, Dresden, Germany). GST-RAB39A was a gift from Pro-
fessor M. Fukuda (Tohoku Univ., Japan). Myc-PICK1, pGEX-PICK1, myc-PDZ
PICK1, ﬂag-D121 PICK1, myc-KDAA PICK1, myc-K83A PICK1, GFP-GluA1 and
GFP-GluA2 were a gift from Dr M. Passafaro (CNR Institute of Neuroscience,
Milan, Italy) and Professor R. Huganir (Johns Hopkins University, Baltimore, MD,
USA). pGEM-PICK1 was created amplifying the full-length rat Pick1 coding
sequence using speciﬁc primers (PICK1 For: 50-GCGCCACCATGTTTGCA-
GACTTAGAC
TATGACAT-30; PICK1 Rev: 50-TCAGGAGTCACACCAGCTTCCG-30). In the
forward primer the KOZAK sequence (CCACC) was inserted. The PCR product
was then cloned into pGEM-T-easy (Promega). Flag-RAB39B was created as
previously described10. pGEX-RAB39B was created amplifying the mouse Rab39b
cDNA from ﬂag-RAB39B vector using speciﬁc primers (pPC86 For: 50-GCGGT
CGACCATGGAGGCCATCTGGCTGTACC-30 ; pGEX Rev: 50-GCGGCGGCCGC
CTAGCACAAACATCTCCTCTCTGA-30), and the PCR product was than
cloned in frame into SalI and NotI sites of p-GEX-4T-2 plasmid (GE Healthcare
Life Sciences).
The site-directed mutagenesis using the Quick Change Lightning kit
(Stratagene) was used to generate nucleotide deletion or mutations on ﬂag-RAB39B
or pGEX-RAB39B to obtain the following plasmids: ﬂag-DER (deletion of 45
nucleotides from þ 105 to þ 147; deletion of 15 amino acids from þ 35 to þ 49),
ﬂag-D38A (mutations on nucleotides from þ 112 to þ 114, mutation on amino
acid þ 38, D38A), ﬂag-V41G42V43AAA (mutations on nucleotides from þ 121 to
þ 129, mutations on amino acids from þ 41 to þ 43, V41A, G42A, V43A), ﬂag-
D44F45AA (mutations on nucleotides from þ 130 to þ 135, mutations on amino
acids from þ 44 to þ 45, D44A, F45A), pGEX-RAB39B S22N (mutations on
nucleotides from þ 63 to þ 65, mutation on amino acid þ 22, S22N), pGEX-
RAB39B Q68L (mutations on nucleotides from þ 64 to þ 66, mutation on amino
acid þ 22, Q68L). pDBleu-RAB39B was created amplifying the human RAB39B
cDNA, obtained from retro-transcription of linfoblastoid cells RNA from control
patients, using speciﬁc primers (pPC86 For: 50-GCGGTCGACCATGGAGGCC
ATCTGGCTGTACC-30; pPC86 Rev: 50-GCGGCGGCCGCTCTAGCACAAACA
TCTCCTCTCTGA-30). The PCR product was than cloned in frame into SalI and
NotI sites of pDB-Leu (ProQuest Two-hybrid system, Gibco BRL). FLAG-
RAB39B-rescue, cherryRAB39B-rescue and GFP-RAB39A was created as
previously described10.
Yeast two-hybrid assay. Yeast two hybrid screening was performed following the
manufacturer’s instruction (ProQuest Two-hybrid system, Gibco BRL). The full-
length human RAB39B cDNA was cloned into the pDBLeu vector, in frame with
PICK1
GluA2
Nucleus
ER
Golgi
RAB39B
Figure 9 | RAB39B-PICK1-GluA2 model acting at ER–Golgi interface.
Proposed model of RAB39B-PICK1-GluA2 complex on a 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) coarse grained liposome model
with a 40nm diameter (grey dots are the atoms of DOPC) emphasizing
RAB39B-driven trafﬁc of GluA2 cargo between the ER and Golgi
compartment.
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the GAL4-binding domain, and used as bait to screen a human foetal brain cDNA
library (ProQuest Pre-made cDNA Libraries) cloned into the pPC86 vector in
frame with the GAL4-activating domain. Positive colonies grew on plates con-
taining 10mM 3-amino-1,2,4-triazole(3-AT) without tryptophan and leucine and
expressed different reporter genes: HIS3 and URA3 allowed the growth, respec-
tively, in medium lacking histidine and uracil, LacZ induced a colorimetric reaction
in the presence of 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal).
cDNA plasmids from positive clones were recovered via TOP10F’ E. coli, plated on
ampicillin and sequenced. Yeast two-hybrid screening was repeated two times and
only positive colonies expressing three reporter genes (HIS3, LacZ and URA3) were
taken in consideration. The test was performed following the manufacturer’s
instructions (ProQuest Two-hybrid system, Gibco BRL).
GST pull-down. GST fusion proteins were prepared in E. coli strain BL21DE3,
isolated and immobilized on glutathione-Sepharose 4B beads (GE Healthcare; as
decribed65). GST pull-down experiments were carried out with mouse brain lysates
or COS7 cells transfected with different constructs or in vitro transcribed and
translated PICK1.
A mouse brain was lysed with HKT buffer (4mM Hepes pH 7.4, 400mM KCl,
4mM EDTA, 2% Triton X-100, Protease Inhibitor cocktail) and rotated at 4 C for
45min before dilution 1:2 with HKT buffer and centrifuging at 16,000 g for 10min
to pellet debris, or it was lysed with RIPA buffer (500mM TrisHCl pH 7.4, 200mM
NaCl, 1mM EDTA, 1% Triton X-100, 1% NP-40, Protease Inhibitor cocktail) and
rotated at 4 C for 1 h before centrifuging at 500 g for 10min to pellet debris.
COS7 cells were transfected with plasmids expressing different PICK1
constructs as myc-PDZ, ﬂag-D121, myc-KDAA, myc-K83A, or different RAB39B
constructs as ﬂag-RAB39B, ﬂag-DER, ﬂag-D38A, ﬂag-V41G42V43AAA, ﬂag-
D44F45AA. After 2 days of transfection, COS7 cells were lysed in RIPA buffer,
rotated at 4 C for 1 h before centrifuging at 12,500 g for 20min to pellet debris and
sonicated for 5min.
PICK1 was in vitro transcribed and translated modifying the standard protocol
(GeHealthcare) as follows: the in vitro reaction was reduced to 30min instead of
90min.
All the lysates were pre-cleared with 120mg GST immobilized on glutathione-
Sepharose 4B beads (GE Healthcare) for 1 h at 4 C.
Forty micrograms of GST-RAB39B in presence of GDP or GTPgS (Sigma-
Aldrich) or 40mg of GST-RAB39B S22N and GST-RAB39B Q68L were incubated
on rotation 3 h at 4 C with 8mg of mouse brain lysed in HKT or RIPA buffer, or
2mg of COS7 cells expressing myc-PDZ, ﬂag-D121, myc-KDAA, myc-K83A or
10ml of the in vitro translational reaction of PICK1. Eighty micrograms of GST-
PICK1 immobilized on glutathione-Sepharose 4B beads were incubated on rotation
3 h at 4 C with 16mg of mouse brain lysed in HKT buffer or 2mg of COS7 cells
expressing ﬂag-RAB39B or ﬂag-RAB39B DER, ﬂag-D38A, ﬂag-V41G42V43AAA
or ﬂag-D44F45AA.
In all the experiments, GST alone and/or GST-RAB5 GDP and GTPgS
immobilized on glutathione-Sepharose 4B beads were used as control.
After washing, the proteins are eluted with elution buffer (25mM Reduced
Glutathione, 500mM Tris pH 8, 300mM NaCl, Protease Inhibitor cocktail) for
30min at RT, resuspended in 5 SDS sample buffer (4% SDS, 1.3M Sucrose,
5mM EDTA, 10% b-mercaptoethanol, 0.5M Tris pH 6.8), analysed by SDS–PAGE
and western blot with appropriate antibodies: the anti-PICK1 polyclonal antibody
(Abcam, #ab3420, 1:500 WB), the anti-PKCa polyclonal antibody (Cell Signaling,
#2056, 1:1,000 WB), anti-p110b polyclonal antibody (Santa Cruz, #sc-602, 1:200
WB), the anti-RAB39B polyclonal antibody (produced by BioGenes against the
hypervariable C-terminal RAB39B sequence CVVHSSEEVIKSERR and tested for
binding speciﬁcity as showed in Supplementary Fig. 1d; 1:500 WB), anti-myc
monoclonal antibody (Sigma-Aldrich; #M4439; 1:5,000 WB) and the anti-FLAG
polyclonal antibody (Sigma-Aldrich, #F1804, 1:1,000 WB), anti-GluA2 monoclonal
antibody (Millipore, #MAB397, 1:200 IF), anti-RAB5 monoclonal antibody (BD
Transduction, #610282, 1:500 WB) and anti-GST polyclonal antibody (Santa Cruz,
#sc-459, 1:500 WB). Band intensity was measured with ImageJ.
Immunoprecipitation. Immunoprecipitation studies were carried out with lysates
prepared from HEK293T cells co-expressing ﬂag-RAB39B and myc-PICK1 or from
wild-type mouse brain or Pick1-knockout mouse brain. Transfected cells were
washed in phosphate-buffered saline (PBS) Ca2þ /Mg2þ (0.1mM CaCl2, 1mM
MgCl2) and scraped in CHAPS buffer (1% CHAPS; Sigma-Aldrich; 0.1mM EDTA
pH 8, Protease Inhibitor Cocktail in PBS solution) and rotated at 4 C for 1 h before
centrifuging at 13,200 g for 20min to pellet debris. Mouse brains were lysed in
HBST buffer (10mM HEPES pH 7.4, 150mM NaCl, 0.5% Triton X-100, Protease
Inhibitor Cocktail in H2O solution), homogenized 10 times by hands, rotated at
4 C for 10min and centrifuged at 13,500 g for 20min at þ 4 C to pellet debris.
All the lysates were pre-cleared with washed protein G-Sepharose-4 fast ﬂow
beads (GE Healthcare/Amersham Biosciences) for 2 h at 4 C.
Immunoprecipitation studies were performed, in presence of 3mM GTPgS
(Sigma-Aldrich), incubating HEK293T cells transfected with ﬂag-RAB39B and
myc-PICK1 with an anti-myc monoclonal antibody (6 mg; Sigma-Aldrich; #M4439)
for 3 h at 4 C on rotation, and wild type or Pick1 KO mouse brain lysates with an
anti-GluA2 monoclonal antibody (5 mg; Millipore; #MAB397) 24 h at 4 C on
rotation. IgG (5mg) was used as a control.
The beads were eluted in 5 SDS sample buffer (4% SDS, 1.3M Sucrose, 5mM
EDTA, 10% b-mercaptoethanol, 0.5M Tris pH 6.8) 10min at room temperature
and analysed by 4–12% polyacrylamide gel on SDS–PAGE and western blot with
appropriate antibodies: anti-myc monoclonal antibody (Covance, #MMS-150P,
1:5,000 WB), anti-FLAG polyclonal antibody (Sigma-Aldrich, #F7425, 1:1,000
WB), anti-GluA2 polyclonal antibody (SySy, #182103, 1:1,000 WB), anti-PICK1
polyclonal antibody (JH2906 was made into the laboratory of Prof. R. Huganir
Johns Hopkins University, Baltimore, MD, USA, 1:250 WB), anti-RAB39B
polyclonal antibody (produced by BioGenes against the hypervariable C-terminal
RAB39B sequence CVVHSSEEVIKSERR; 1:500 WB).
Cell cultures, transfection and lentiviral transduction. COS7 and HEK293T
cells were grown in Dulbecco’s modiﬁed Eagle’s medium (Gibco) supplemented
with 10% fetal bovine serum (Gibco), 1% glutamine, 1% penicillin and strepto-
mycin and were regularly passaged to maintain exponential growth. COS7 cells
were transfected using Lipofectamine 2000 (Invitrogen) following the manu-
facturer’s instructions and ﬁxed 24 h after transfection.
Mouse hippocampal neurons were transduced (MOI1) at DIV1 with lentiviral
particles expressing shScramble or shRab39b as previously described10. See
Supplementary Experimental Procedures for details.
Deglycosilation. Instructions for the use of EndoHf and PNGasef (NEB) were
followed according to the manufacturer’s instructions to digest proteins, with
minor modiﬁcations. In brief, cultured hippocampal neurons transduced with
shRab39b or shScramble were lysed with Lysis Buffer (1% SDS, 2mM EDTA,
10mM hepes pH 7,4, Protease Inhibitor Cocktail). A total of 260 mg of lysed were
for denatured 15min at 55 C and digested with EndoHf or PNGasef for 2 h at
37 C. SDS loading buffer (5 ) was ﬁnally added to samples, which were split in
three different parts, 30, 30 and 200 mg, and analysed by western blot with 6% SDS–
PAGE. GluA1, GluA2 and GluA3 were detected using a anti-GluA1 polyclonal
antibody (SySy, #182003, 1:1,000 WB), anti-GluA2 polyclonal antibody (SySy;
#182103, 1:1,000 WB) and anti-GluA3 polyclonal antibody (made into the
laboratory of Professor R. Huganir Johns Hopkins University, Baltimore, MD,
USA, 1:1,000 WB).
Immunoﬂuorescence. Standard immunoﬂuorescence experiments were carried
out by ﬁxing the cells for 15min with 4% paraformaldehyde, 4% sucrose (Sigma-
Aldrich) in 120mM sodium phosphate buffer, pH 7.4. Coverslips were rinsed three
times with PBS and then incubated overnight at 4 C into a humidiﬁed chamber
with the primary antibody (anti-ﬂag polyclonal antibody: Sigma-Aldrich; poly
#F7425, 1:200 IF, anti-ﬂag monoclonal antibody: Sigma-Aldrich, #F1804, 1:400 IF;
anti-myc monoclonal antibody: Sigma-Aldrich; #M4439; 1:5,000 WB and 1:400 IF;
anti-PICK1: Thermo Scientiﬁc, #PA1-073, 1:100 IF; anti-calreticulin: Sigma,
#C4606, 1:500 IF; anti-GM130: BD Transduction, #610823, 1:50 IF) appropriately
diluted in goat serum dilution buffer (GSDB; 15% goat serum, 450mM NaCl, 0.3%
Triton X-100, 20mM sodium phosphate buffer, pH 7.4). Coverslips were washed
three times within 30min with high salt buffer (HS: 500mM NaCl, 20mM sodium
phosphate buffer, pH 7.4) and then incubated with the appropriate secondary
antibodies (Molecular Probes, Invitrogen) for 90min at room temperature. After
three washes with HS over 30min and one wash with 5mM sodium phosphate
buffer, pH 7.4, and coverslips were mounted with Vectashield (Vectalab).
Visualization of intracellular endogenous AMPAR subunits in neurons was
done by hiding the portion of receptors exposed on the membrane surface with
primary monoclonal antibodies recognizing the N-terminal portion (anti-GluA1:
Millipore, #MAB2263, 1: 1:200 IF; anti-GluA2: Millipore, #MAB397, 1:200 IF; anti-
GluA3: made into the laboratory of Prof. R. Huganir Johns Hopkins University,
Baltimore, MD, USA, 1:100 IF) diluted in GSDB without Triton X-100 as well as
the HRP-conjugated secondary antibody (Biorad, 1:200), and then cells were
incubated with the primary monoclonal antibodies recognizing the N-terminal
portion diluted in GSDB with 0.3% Triton X-100 as well as the appropriate
secondary antibody (Molecular Probes, Invitrogen).
To visualize GluA1 and GluA2 exposed on the cell surface, the primary
monoclonal antibodies recognizing the N-terminal portion were diluted in GSDB
without Triton X-100, as well as the secondary antibody (Molecular Probes,
Invitrogen).
Image acquisition and analysis. For Western blots, ImageJ Analysis Software
(‘Analyze gels’ plugin) was used; full scan of western blots is shown in
Supplementary Fig. 6. For GST pull-down experiments, PICK1 binding to GST-
RAB39B GDP versus GST-RAB39B GTPgS is quantiﬁed as follow: signal from
GST-RAB39B GTPgS binding protein is normalized on the 50 kDa GST signal and
set at 100%; consequently, the level of GST-RAB39B GDP binding protein, nor-
malized on the 50 KDa GST band, is expressed as percentage of 100.
Confocal images of COS7 cells were obtained using Leica SP8 SMD laser
scanning confocal. For spine morphology ﬂuorescent images were acquired with a
Biorad MRC1024 confocal microscope, using a Nikon 60 objective with
sequential acquisition setting at 1,280 1,024 pixel resolution and image data were
a z series projection of about 5–10 images, each averaged 4 times and taken at
0.7 mm depth intervals.
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Pictures of immunostained hippocampal neurons were captured with the same
exposure conditions using DeltaVision microscope (Applied Precision) equipped
with a  60 or  100 objectives. At least 10 Z-space slices of 0.20 mm were
deconvolved and ﬂattened by maximum projection.
TIRF images, setting 110 nm as the distance from the coverslip, were acquired
using Leica SR GSD 3D TIRF microscope (Leica).
Pearson’s correlation coefﬁcient was calculated using Volocity software to
measure the correlation between two proteins.
Morphometric spine measurements were made with NeuronStudio software.
ImageJ Analysis Software (‘Gran ﬁlter’ plugin setting the size from 1 to inﬁnity)
was used to measure AMPAR subunits and PICK1 density relatively to the area of
infected cell body and dendrites.
Electrophysiology in cultured hippocampal neurons. Seventeen to twenty DIV
hippocampal neurons transduced at low or high MOI with shScramble or
shRab39b, and in some case transfected with Rab39b as rescue, were patched and
whole-cell recordings were made on infected neurons held at  70mV in the
presence of 3 mM TTX. mEPSCs were acquired until the cell was stable and ana-
lysed using pClamp10 (Molecular Devices). Threshold mEPSC amplitude was set at
5 pA, and 300–500 events were collected and averaged to calculate the mean
mEPSC amplitude, frequency and kinetics for each culture preparation examined.
See Supplementary Experimental Procedures for details.
Electrophysiology in organotypic hippocampal slices. Hippocampal slice cul-
tures were prepared from postnatal day 5–7 mice C57BL/6N. After 1 day in culture
every slice was transduced with lentiviral particles (shScramble or shRab39b). After
10–12 days in culture, simultaneous voltage-clamp whole-cell recordings were
obtained from nearby infected and uninfected CA1 pyramidal neurons. Whole-cell
recordings were made with a Multiclamp 700B ampliﬁer (Axon Instruments) and
electrophysiological data were collected with pCLAMP software (Molecular
Devices). See Supplementary Experimental Procedures for details.
Statistical analysis. Data are expressed as mean±s.e.m. Statistical signiﬁcance
was assessed using paired Student’s t-test as appropriate (for two groups
comparison). We veriﬁed the difference between groups by means of t-type
test statistic and exact P values computed with permutation methods to avoid
any distributional assumption or asymptotical approximation. P values were,
then, adjusted for multiplicity applying the Benjamini–Hochberg procedure
(false discovery rate)66.
Molecular modelling. The structural models of PICK1 and RAB39B were
achieved by comparative modelling (that is, by MODELLER67), whereas the
interaction between them was predicted by protein docking (that is, by ZDOCK68).
The CTD of GluA2 was built by comparative modelling as well. Details of
Computational modelling are provided as Supplementary Information.
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